β-lactam resistance in Streptococcus mitis isolated from saliva of healthy subjects

Journal of Infection and Chemotherapy

Volumn 9, Issue 4, 2003, Pages 321-327

  Nakayama, Ayako ^a   Takao, Ayuko ^a  

^a TSURUMI UNIVERSITY   (Japan)

Author keywords

Bactericidal effect; Minimum inhibitory concentrations (MICs); Penicillin binding protein genes; Penicillin binding proteins (PBPs); Streptococcus mitis; Lactam resistant streptococci

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; GENE PRODUCT; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 1A; PENICILLIN BINDING PROTEIN 2A; PENICILLIN BINDING PROTEIN 2B; PENICILLIN BINDING PROTEIN 2X; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL SURVIVAL; BINDING AFFINITY; CONCENTRATION RESPONSE; DRUG PROTEIN BINDING; GENE; GENE MUTATION; HUMAN; HUMAN EXPERIMENT; MINIMUM INHIBITORY CONCENTRATION; MOUTH FLORA; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PBP GENE; SALIVA ANALYSIS; SEQUENCE HOMOLOGY; STRAIN IDENTIFICATION; STREPTOCOCCUS MITIS;

EID: 0346732985     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-003-0286-y     Document Type: Article

References (34)

1. Socransky SS, Manganiello SD. The oral microbiota of man from birth to senility. J Periodontol 1971;42:485-96.
2. Lucas VS, Beighton D, Roberts GJ, Challacombe SJ. Changes in the oral streptococcal flora of children undergoing allogeneic bone marrow transplantation. J Infect 1997;35:135-41.
3. Doern GV, Ferraro MJ, Brueggemann AB, Ruoff KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996:40:891-4.
4. Sasaki J, Kaneko A. Prevention of endocarditis caused by transient bacteremia after tooth extraction (in Japanese). J Jpn Assoc Dent 2001;20:49-57.
5. Sabella C, Murphy D, Drummond-Webb J. Endocarditis due to Streptococcus mitis with high-level resistance to penicillin and ceftriaxone. JAMA 2001;285:2195.
6. Bochud PY, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med 1994;97:256-64.
7. Saito K, Kaneko A, Takakura A, Arai I, Matuzaki K, Kobayashi I. Clinical isolates from odontogenic infections and their antibiotic susceptibilities (in Japanese). Jpn J Chemother 2001;49:30-5.
8. Amoroso A, Demares D, Mollerach M, Gutkind G, Coyette J. All detectable high-molecular-mass penicillin-binding proteins are modified in a high-level β-lactam-resistant clinical isolate of Streptococcus mitis. Antimicrob Agents Chemother 2001;45:2075-81.
9. Spratt BG. Resistance to β-lactam antibiotics mediated by alterations of penicillin-binding proteins. In: Bryan LE, editor. Microbial resistance to drugs. Tokyo New York Heidelberg Berlin: Springer; 1989;91:77-100.
10. Ghuysen JM. Serine β-lactamase and penicillin-binding proteins. Annu Rev Microbiol 1991;45:37-67.
11. Asahi Y, Takeuchi Y, Ubukata K. Diversity of substitutions within or adjacent to conserved amino acid motifs of penicillin-binding protein 2X in cephalosporin-resistant Streptococcus pneumoniae isolates. Antimicrob Agents Chemother 1999;43:1252-5.
12. Shibasaki Y, Ubukata K. β-Lactam and macrolide resistance in Streptococcus pneumoniae (in Japanese). Nippon Rinsho 2001;59:681-6.
13. Dowson CG, Coffey TJ, Kell C, Whiley RA. Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae. Mol Microbiol 1993;9:635-43.
14. Kawamura Y, Whiley RA, Shu SE, Ezaki T, Hardie JM. Genetic approaches to the identification of the mitis group within the genus Streptococcus. Microbiology 1991;145:2605-13.
15. Cartwright K. Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management. Eur J Pediatr 2002;161:188-95.
16. Wisplinghoff H, Reinert RR, Cornely O, Seifert H. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. J Clin Microbiol 1999;37:1876-80.
17. Zhao G, Meier TI, Kahl SD, Gee KR, Blaszczak LC, Bocillin FL, a sensitive and commercially available reagent for detection of penicillin-binding proteins. Antimicrob Agents Chemother 1999;43:1124-8.
18. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibilitiy test for bacteria that grow aerobically: approved standard. 5th Ed. Document M7-A5. Wayn, PA: NCCLS; 2000.
19. Spangler SK, Jacobs MR, Appelbaum PC. Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other β-lactams. J Antimicrob Chemother 1997;39:141-8.
20. Bowden GH, Hamilton IR. Survival of oral bacteria. Crit Rev Oral Biol Med 1998;9:54-85.
21. Konig A, Reinert RR, Hakenbeck R. Streptococcus mitis with unusually high level resistance to β-lactam antibiotics. Microb Drug Resist 1998;4:45-9.
22. Sasaki F, Study on β-lactam antibiotic susceptibilities and characteristics of penicillin binding proteins of ampicillin resistant streptococci isolated from healthy adults' saliva (in Japanese). Jpn J Chemother 1998;46:375-86.
23. Konno K, Ubukata K. Penicillin resistant Streptococcus pneumoniae (in Japanese). Tokyo: Kyowa Kikaku Tsushin; 1997.
24. Ubukata K, Muraki T, Igarashi A, Asahi Y, Konno M. Identification of penicillin and other beta-lactam resistance in Streptococcus pneumoniae by polymerase chain reaction. J Infect Chemother 1997;3:190-7.
25. Reichmann P, Konig A, Linares J, Alcaide F, Tenover FC, McDougal L, et al. A global gene pool for high-level cephalosporin resistance in commensal Streptococcus species and Streptococcus pneumoniae. J Infect Dis 1997;176:1001-12.
26. du Plessis M, Bingen E, Klugman KP. Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin. Antimicrob Agents Chemother 2002;46:2349-57.
27. Sjovall J. Dose dependence in human absorption of amino-penicillins. Infection 1979;Suppl 5:458-62.
28. Otsuru M, Kaneko A, Mori Y, Nakatogawa N, Sasaki J, Yamane N, et al. Pharmacokinetic study of one dose of 750mg of amoxicillin (in Japanese). Oral Ther Pharmacol 2001;20:78-81.
29. Andes D, Craig WA. In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations. Antimicrob Agents Chemother 1998;42:2375-9.
30. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997;277:1794-801.
31. Hall GE, Baddour LM. Apparent failure of endocarditis prophylaxis caused by penicillin-resistant Streptococcus mitis. Am J Med Sci 2002;324:51-3.
32. Harrison GA, Rubin MP, Davies RM, Speller DC. Resistance in oral streptococci after repetition of a single-dose amoxycillin prophylactic regimen. J Antimicrob Chemother 1985;15:501-3.
33. Guillemont D, Carbon C, Balkau B, Geslin P, Lecoeur H, Vauzelle-Kervroedan F, et al. Low dosage and long treatment duration of β-lactam: risk factors for carriage of penicillin-resistant streptococcus pneumonia. JAMA 1998;279:365-70.
34. Schrag SJ, Pena C, Fernandez J, Sanchez J, Gomez V, Perez E, et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. JAMA 2001;286:49-56.